Biosenta Inc. Enters Into an MOU With Voran Group Ventures Ltd. to Collaborate on the Commercialization of Biosenta’s Tri-Filler® Products
Biosenta Inc. Enters Into an MOU With Voran Group Ventures Ltd. to Collaborate on the Commercialization of Biosenta’s Tri-Filler® Products
CALGARY, Alberta, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Biosenta Inc. (the "Company" or "Biosenta") (CSE: ZRO) has signed a milestone Memorandum of Understanding dated October 5, 2022, with VORAN GROUP VENTURES Ltd. ("Voran") which will lead the way for the commercialization of Biosenta's Tri-Filler® antimicrobial products in Canadian markets and worldwide.
艾伯塔省卡爾加里，2022 年 10 月 12 日（環球新聞專線）— Biosenta Inc.（“公司” 或 “Biosenta”）（CSE：ZRO） 已於2022年10月5日與VORAN GROUP VENTURES Ltd.（“Voran”）簽署了一份具有里程碑意義的諒解備忘錄，這將引領Biosenta的Tri-Filler® 抗菌產品在加拿大市場和全球的商業化道路。
The patented new material science Tri-Filler® products could set the new standard in antimicrobial materials as a safe and proactive option against biological and ecological threats.
獲得專利的新材料科學 Tri-Filler® 產品可以爲抗菌材料樹立新標準，成爲抵禦生物和生態威脅的安全而主動的選擇。
"Tri-Filler® has the potential to make a positive impact to the antimicrobial properties of everyday surfaces," said Am Gill, President and CEO of Biosenta Inc. "We are thrilled to be working with Voran to bring Tri-Filler® to the world marketplace."
“Tri-Filler® 有可能對日常表面的抗菌特性產生積極影響，” Biosenta Inc.總裁兼首席執行官艾姆·吉爾說，“我們很高興能與Voran合作，將Tri-Filler® 推向世界市場。”
Chelsey Reschke, President and CEO of Voran Group, commented, "Establishing this MOU is the first milestone in our collaboration with Biosenta and we are delighted to be selected as a commercialization partner. The tremendous versatility of the Tri-Filler® products has the potential to revolutionize manufactured building materials and replace existing GHG-intensive commercial fillers. We are especially pleased to work with an impact-driven company like Biosenta."
Voran集團總裁兼首席執行官切爾西·雷施克評論說：“建立這份諒解備忘錄是我們與Biosenta合作的第一個里程碑，我們很高興被選爲商業化合作夥伴。Tri-Filler® 產品的巨大多功能性有可能徹底改變人造建築材料並取代現有的溫室氣體密集型商用填料。我們特別高興能與像Biosenta這樣以影響力爲導向的公司合作。”
Biosenta's Tri-Filler® is currently being tested at the University of Calgary with very encouraging results (please refer to News Release dated May 25, 2022). Additional updates will be provided in coming weeks.
Biosenta 的 Tri-Filler® 目前正在卡爾加里大學進行測試，結果非常令人鼓舞（請參閱 2022 年 5 月 25 日的新聞稿）。未來幾周將提供更多更新。
About Biosenta Inc.
關於 Biosenta Inc.
Biosenta is a Canadian-based company that develops and manufactures a range of safe and environmentally sound chemical compounds for household and industrial applications.
Biosenta 是一家總部位於加拿大的公司，爲家庭和工業應用開發和製造一系列安全和環保的化合物。
About Voran: Based in Sherwood Park, Alberta, Voran Group is a leader in the development, commercialization, and distribution of advanced antimicrobial solutions. Voran's pipeline of new products is driven by the demand of its customers, industry, and communities for safer, future-focused solutions. Voran's capabilities in obtaining market authorizations under the most rigorous global regulatory requirements is the key differentiator in delivering results for its partners and customers.
關於 Voran: Voran Group 總部位於艾伯塔省舍伍德公園，是開發、商業化和分銷先進抗微生物解決方案的領導者。Voran 的新產品系列是由其客戶、行業和社區對更安全、面向未來的解決方案的需求推動的。Voran 在最嚴格的全球監管要求下獲得市場授權的能力是爲其合作伙伴和客戶提供業績的關鍵差異化因素。
Disclaimer
免責聲明
The CSE has in no way passed upon the contents of this news release and further, has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
CSE絕沒有透露本新聞稿的內容，此外，它既沒有批准也沒有不贊成本新聞稿的內容。CSE 及其監管服務提供商（該術語在 CSE 政策中定義）均不對本新聞稿的充分性或準確性承擔責任。
Forward-Looking Statements
前瞻性陳述
This press release contains forward-looking information within the meaning of applicable securities laws ("forward-looking statements"), including forward-looking statements relating the completion of the Transaction. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. If any such risks actually occur, they could impact the potential for discussion, agreement or completion of the Transaction and/or materially adversely affect the Company's business, financial condition or results of operations. In that case, the trading price of the Company's common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
本新聞稿包含適用證券法所指的前瞻性信息（“前瞻性陳述”），包括與交易完成有關的前瞻性陳述。此類前瞻性陳述涉及已知和未知的風險、不確定性、假設和其他因素，這些因素可能導致實際業績、業績或成就與此類前瞻性陳述所表達或暗示的預期業績、業績或成就或發展存在重大差異。如果實際發生任何此類風險，則可能會影響討論、達成協議或完成交易的可能性和/或對公司的業務、財務狀況或經營業績產生重大不利影響。在這種情況下，公司普通股的交易價格可能會大幅下跌。提醒讀者不要過分依賴任何此類前瞻性陳述，這些陳述僅代表截至發表之日。提供前瞻性陳述的目的是提供有關管理層當前預期和未來計劃的信息。提醒讀者，此類信息可能不適用於其他目的。除非法律要求，否則公司不承擔或接受任何義務或承諾，即公開發布任何前瞻性陳述的任何更新或修訂，以反映公司預期的任何變化或任何此類陳述所依據的事件、條件或情況的任何變化。
For Further Information please contact:
欲瞭解更多信息，請聯繫：
Am Gill, President and CEO of Biosenta Inc.
am@biosenta.com
or
Chelsey Reschke, President and CEO of Voran Group Ventures Ltd.
creschke@vorangroup.ca
Am Gill，Biosenta Inc. 總裁兼首席執行官
am@biosenta.com
要麼
切爾西·雷施克，Voran Group Ventures Ltd總裁兼首席執行官
creschke@vorangroup.ca
譯文內容由第三人軟體翻譯。